Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: Development of topical formulation

Carcinogenesis

Volumn 31, Issue 11, 2010, Pages 2004-2011

  Vaid, Mudit ^a   Sharma, Som D ^a   Katiyar, Santosh K ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; CYCLOOXYGENASE 2; CYTOKINE; HONOKIOL; INTERLEUKIN 1BETA; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN KINASE B; PROTEIN P21; PROTEIN P27; SERINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CREAM; DRUG EFFICACY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; HAIRLESS MOUSE; HYDROPHILICITY; IMMUNOHISTOCHEMISTRY; MAGNOLIACEAE; MOUSE; NONHUMAN; PHOTOCARCINOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION INDUCED NEOPLASM; SKIN CANCER; SKIN CARCINOGENESIS; TUMOR GROWTH; ULTRAVIOLET B RADIATION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS; BIPHENYL COMPOUNDS; BLOTTING, WESTERN; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASES; CYCLOOXYGENASE 2; DRUGS, CHINESE HERBAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOENZYME TECHNIQUES; INFLAMMATION MEDIATORS; LIGNANS; MAGNOLIA; MICE; MICE, HAIRLESS; PAPILLOMA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 78149234280     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq186     Document Type: Article

References (47)

1. Housman, T.S. et al. (2003) Skin cancer is among the most costly of all cancers to treat for the Medicare population. J. Am. Acad. Dermatol., 48, 425-429.
2. Baliga, M.S. et al. (2006) Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem. Photobiol. Sci., 5, 243-253.
3. Li, T.S.C. (2002) Chinese and Related North American Herbs: Phytopharmacology and Therapeutic Values. CRC Press, Boca Raton, FL.
4. Hahm, E.R. et al. (2008) Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin. Cancer Res., 14, 1248-1257.
5. Bai, X. et al. (2003) Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J. Biol. Chem., 278, 35501-35507.
6. Munroe, M.E. et al. (2007) Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J. Immunol., 179, 753-763.
7. Pyo, M.K. et al. (2002) Anti-platelet effect of the constituents isolated from the barks and fruits of Magnolia obovata. Arch. Pharm. Res., 25, 325-328.
8. Clark, A.M. et al. (1981) Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J. Pharm. Sci., 70, 951-952.
9. Park, J. et al. (2004) In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur. J. Pharmacol., 496, 189-195.
10. Mittal, A. et al. (2003) Exceptionally high protection of photocarcinogenesis by topical application of (-)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVBinduced global DNA hypomethylation. Neoplasia, 5, 555-565.
11. Mukhtar, H. et al. (1996) Photocarcinogenesis: mechanisms, models and human health implications. Photochem. Photobiol., 63, 355-447.
12. Katiyar, S.K. (2006) Oxidative stress and photocarcinogenesis: strategies for prevention. In Singh, K.K. (ed.) Oxidative Stress, Disease and Cancer. Imperial College Press, London, UK, pp. 933-964.
13. Katiyar, S.K. et al. (2000) Kinetics of UV light-induced cyclobutane pyrimidine dimers in human skin in vivo: an immunohistochemical analysis of both epidermis and dermis. Photochem. Photobiol., 72, 788-793.
14. Meeran, S.M. et al. (2009) Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation. J. Invest. Dermatol., 129, 1258-1270.
15. Rivas, J.M. et al. (1994) The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation. J. Leukoc. Biol., 56, 769-775.
16. Katiyar, S.K. et al. (1999) Prevention of UVB-induced immunosuppression in mice by green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis, 20, 2117-2124.
17. Meeran, S.M. et al. (2008) Interleukin-12-deficiency exacerbates inflammatory responses in UV-irradiated skin and skin tumors. J. Invest. Dermatol., 128, 2716-2727.
18. Meeran, S.M. et al. (2009) Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7, 12-dimethylbenz(a)anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Carcinogenesis, 30, 520-528.
19. DiGiovanni, J. (1992) Multistage carcinogenesis in mouse skin. Pharmacol. Ther., 54, 63-128.
20. Hong, J.T. et al. (2001) Inhibitory effect of glycolic acid on ultravioletinduced skin tumorigenesis in SKH-1 hairless mice and its mechanism of action. Mol. Carcinog., 31, 152-160.
21. Meeran, S.M. et al. (2008) Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front. Biosci., 13, 2191-2202.
22. Graña, X. et al. (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene, 11, 211-219.
23. Chun, K.S. et al. (2007) Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4. Cancer Res., 67, 2015-2021.
24. Luo, J. et al. (2003) Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell, 4, 257-262.
25. Nomura, M. et al. (2001) Mitogen-and stress-activated protein kinase 1 mediates activation of Akt by ultraviolet B irradiation. J. Biol. Chem., 276, 25558-25567.
26. Chilampalli, S. et al. (2010) Chemopreventive effects of honokiol on UVBinduced skin cancer development. Anticancer Res., 30, 777-783.
27. Lu, Y.P. et al. (2009) Tumorigenic effect of some commonly used moisturizing creams when applied topically to UVB-pretreated high-risk mice. J. Invest. Dermatol., 129, 468-475.
28. Langenbach, R. et al. (1999) Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis. Ann. N. Y. Acad. Sci., 889, 52-61.
29. Chapple, K.S. et al. (2000) Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am. J. Pathol., 156, 545-553.
30. Marks, F. et al. (1999) Metabolic targets of cancer chemoprevention: interruption of tumor development by inhibitors of arachidonic acid metabolism. Recent Results Cancer Res., 151, 45-67.
31. Williams, C.S. et al. (1999) The role of cyclooxygenases in inflammation, cancer, and development. Oncogene, 18, 7908-7916.
32. Buckman, S.Y. et al. (1998) COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis, 19, 723-729.
33. Athar, M. et al. (2001) Ultraviolet B (UVB)-induced COX-2 expression in murine skin: an immunohistochemical study. Biochem. Biophys. Res. Commun., 280, 1042-1047.
34. Wilgus, T.A. et al. (2003) Inhibition of cutaneous ultraviolet light Bmediated inflammation and tumor formation with topical celecoxib treatment. Mol. Carcinog., 38, 49-58.
35. Pentland, A.P. et al. (1999) Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis, 20, 1939-1944.
36. Ahn, K.S. et al. (2006) Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factorkappaB activation pathway. Mol. Cancer Res., 4, 621-633.
37. Scott, K.A. et al. (2003) An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors. Mol. Cancer Ther., 2, 445-451.
38. Tron, V.A. et al. (1988) Epidermal interleukin-1 is increased in cutaneous T-cell lymphoma. J. Invest. Dermatol., 90, 378-381.
39. Sherr, C.J. et al. (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev., 13, 1501-1512.
40. Morgan, D.O. (1995) Principles of CDK regulation. Nature, 374, 131-134.
41. Fotedar, R. et al. (2004) Role of p21WAF1 in the cellular response to UV. Cell Cycle, 3, 134-137.
42. Tyrrell, R.M. (1996) Activation of mammalian gene expression by the UV component of sunlight-from models to reality. Bioessays, 18, 139-148.
43. Saleem, M. et al. (2004) Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene, 23, 5203-5214.
44. Osaki, M. et al. (2004) Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45. J. Cancer Res. Clin. Oncol., 130, 8-14.
45. Downward, J. (1998) Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol., 10, 262-267.
46. Callejas, N.A. et al. (1999) Requirement of nuclear factor kappaB for the constitutive expression of nitric oxide synthase-2 and cyclooxygenase-2 in rat trophoblasts. J. Cell Sci., 18, 3147-3155.
47. Carpenter, C.L. et al. (1996) Phosphoinositide kinases. Curr. Opin. Cell Biol., 8, 153-158.